Nirvana Life Sciences (XCNQ:NIRV) EV-to-EBIT : -1.59 (As of May. 27, 2024)

Nirvana Life Sciences EV-to-EBIT Chart

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															-4.95	-0.72	-1.05	-1.32	-1.78

Competitive Comparison of Nirvana Life Sciences's EV-to-EBIT

For the Biotechnology subindustry, Nirvana Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's EV-to-EBIT falls into.

Nirvana Life Sciences EV-to-EBIT Calculation

Nirvana Life Sciences's EV-to-EBIT for today is calculated as:

Nirvana Life Sciences's current Enterprise Value is C$1.95 Mil.
Nirvana Life Sciences's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences  (XCNQ:NIRV) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Nirvana Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Nirvana Life Sciences's Enterprise Value for the quarter that ended in Jan. 2024 was C$2.19 Mil.
Nirvana Life Sciences's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences (XCNQ:NIRV) Business Description